Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Ben-Joseph

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
International Journal of Cardiology|October 16, 2003
National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United KingdomAmeet Bakhai, Marcus D Flather, Julian R Collinson, et al.
Applied Health Economics and Health Policy|June 13, 2014
Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims dataJ Bradford Rice, Noam Y Kirson, Amie Shei, et al.
Journal of Managed Care & Specialty Pharmacy|September 25, 2015
Characteristics of High-Cost Patients Diagnosed with Opioid AbuseAmie Shei, J Bradford Rice, Noam Y Kirson, et al.
Pain Medicine (Malden, Mass.)|May 2, 2015
The Burden of Undiagnosed Opioid Abuse Among Commercially Insured IndividualsNoam Y Kirson, Amie Shei, J Bradford Rice, et al.
Population Health Management|August 12, 2009
Cardiometabolic risk and health care utilization and cost for Hispanic and non-Hispanic womenSarah J Beaton, Scott B Robinson, Ann Von Worley, et al.
Postgraduate Medicine|August 21, 2014
The economic burden of diagnosed opioid abuse among commercially insured individualsJ Bradford Rice, Noam Y Kirson, Amie Shei, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
International Journal of Cardiology|October 16, 2003
National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United KingdomAmeet Bakhai, Marcus D Flather, Julian R Collinson, et al.
Applied Health Economics and Health Policy|June 13, 2014
Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims dataJ Bradford Rice, Noam Y Kirson, Amie Shei, et al.
Journal of Managed Care & Specialty Pharmacy|September 25, 2015
Characteristics of High-Cost Patients Diagnosed with Opioid AbuseAmie Shei, J Bradford Rice, Noam Y Kirson, et al.
Pain Medicine (Malden, Mass.)|May 2, 2015
The Burden of Undiagnosed Opioid Abuse Among Commercially Insured IndividualsNoam Y Kirson, Amie Shei, J Bradford Rice, et al.
Population Health Management|August 12, 2009
Cardiometabolic risk and health care utilization and cost for Hispanic and non-Hispanic womenSarah J Beaton, Scott B Robinson, Ann Von Worley, et al.
Postgraduate Medicine|August 21, 2014
The economic burden of diagnosed opioid abuse among commercially insured individualsJ Bradford Rice, Noam Y Kirson, Amie Shei, et al.
Pageof 4